1. Home
  2. BTZ vs AMPH Comparison

BTZ vs AMPH Comparison

Compare BTZ & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTZ
  • AMPH
  • Stock Information
  • Founded
  • BTZ 2006
  • AMPH 1996
  • Country
  • BTZ United States
  • AMPH United States
  • Employees
  • BTZ N/A
  • AMPH N/A
  • Industry
  • BTZ Finance Companies
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BTZ Finance
  • AMPH Health Care
  • Exchange
  • BTZ Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • BTZ 999.5M
  • AMPH 1.1B
  • IPO Year
  • BTZ N/A
  • AMPH 2014
  • Fundamental
  • Price
  • BTZ $10.59
  • AMPH $23.42
  • Analyst Decision
  • BTZ
  • AMPH Buy
  • Analyst Count
  • BTZ 0
  • AMPH 4
  • Target Price
  • BTZ N/A
  • AMPH $40.67
  • AVG Volume (30 Days)
  • BTZ 279.4K
  • AMPH 578.6K
  • Earning Date
  • BTZ 01-01-0001
  • AMPH 05-07-2025
  • Dividend Yield
  • BTZ 9.40%
  • AMPH N/A
  • EPS Growth
  • BTZ N/A
  • AMPH N/A
  • EPS
  • BTZ 1.41
  • AMPH 2.77
  • Revenue
  • BTZ N/A
  • AMPH $730,659,000.00
  • Revenue This Year
  • BTZ N/A
  • AMPH $2.32
  • Revenue Next Year
  • BTZ N/A
  • AMPH $6.60
  • P/E Ratio
  • BTZ $7.57
  • AMPH $8.99
  • Revenue Growth
  • BTZ N/A
  • AMPH 8.05
  • 52 Week Low
  • BTZ $9.10
  • AMPH $22.64
  • 52 Week High
  • BTZ $11.13
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • BTZ 56.28
  • AMPH 47.79
  • Support Level
  • BTZ $10.44
  • AMPH $23.68
  • Resistance Level
  • BTZ $10.64
  • AMPH $25.36
  • Average True Range (ATR)
  • BTZ 0.10
  • AMPH 0.80
  • MACD
  • BTZ 0.03
  • AMPH 0.26
  • Stochastic Oscillator
  • BTZ 83.91
  • AMPH 70.00

About BTZ BlackRock Credit Allocation Income Trust

Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: